Emanuela Palmerini (@manupalmerini) 's Twitter Profile
Emanuela Palmerini

@manupalmerini

ID: 1219305115

calendar_today25-02-2013 16:46:48

257 Tweet

274 Followers

308 Following

Italian Sarcoma Group (@itasarcomagroup) 's Twitter Profile Photo

📣Giovedì 30 gennaio alle ore 13.30 su #Rai2 , nella rubrica del Tg2🟥"Tutto il bello che c'è" andrà in onda un servizio sull'Italian Sarcoma Group ISG. 🎗️ Per vederlo in diretta streaming ➡️ raiplay.it/dirette/rai2 #30gennaio #ItalianSarcomaGroup

📣Giovedì 30 gennaio alle ore 13.30 su #Rai2 , nella rubrica del Tg2🟥"Tutto il bello che c'è" andrà in onda un servizio sull'Italian Sarcoma Group ISG. 🎗️
Per vederlo in diretta streaming ➡️ raiplay.it/dirette/rai2

#30gennaio #ItalianSarcomaGroup
Emanuela Palmerini (@manupalmerini) 's Twitter Profile Photo

Grateful to Filippo family and #iosonofilippo patient advocacy to support Rizzoli IRCCS #research for #osteosarcoma and perpetuate Filippo memory! canottaggio.org/news/2025/io-s… #sarcoma #research Foster MIB Agents Osteosarcoma Alliance The Osteosarcoma Institute

Grateful to Filippo family and #iosonofilippo patient advocacy to support <a href="/IRCCS_Rizzoli/">Rizzoli IRCCS</a> #research for #osteosarcoma and perpetuate Filippo memory! canottaggio.org/news/2025/io-s… #sarcoma #research <a href="/FosterConsorti1/">Foster</a> <a href="/AgentsMIB/">MIB Agents Osteosarcoma Alliance</a> <a href="/OSInstitute/">The Osteosarcoma Institute</a>
Myriam Chalabi (@myriamchalabi) 's Twitter Profile Photo

Abstract submission now open for #ESMO25 in #BERLIN! We have a fantastic educational programme in place, and now it's time for the scientific programme. Looking forward to your abstracts! Deadline: May13th esmo.org/meeting-calend… Toni Choueiri, MD ESMO - Eur. Oncology Toni Choueiri, MD FabriceAndre

ESMO Open (@esmo_open) 's Twitter Profile Photo

Final results from the phase Ia/Ib study of the bromodomain and extra-terminal domain inhibitor BI 894999 in pts with advanced solid tumors/DLBCL in ESMO Open.DLTs in 4 pts with DLBCL and 17 with solid tumors. No further investigation due to low activity. esmoopen.com/article/S2059-…

Final results from the phase Ia/Ib study of the bromodomain and extra-terminal domain inhibitor BI 894999 in pts with advanced solid tumors/DLBCL in <a href="/ESMO_Open/">ESMO Open</a>.DLTs in 4 pts with DLBCL and 17 with solid tumors. No further investigation due to low activity. esmoopen.com/article/S2059-…
CTOS (@ctosociety) 's Twitter Profile Photo

CTOS President Silvia Stacchiotti is inviting everyone to join the Annual Meeting in Boca Raton and celebrate 30th Anniversary of the Society! Get ready and prepare your abstracts! Especially on the #sarcoma of the year 🌟#chondrosarcoma #CTOS2025 #CTOSTweeTOS

Jon Trent, MD, PhD (@jtrentmdphd) 's Twitter Profile Photo

Please join me in the Trainee & Early Career Lounge Located in Hall C for specialized programming, complimentary refreshments, and a comfortable space to relax for Student, Resident, Fellow, and Early Career Oncologists. #ASCO25 ASCO Sylvester Comprehensive Cancer Center

Please join me in the Trainee &amp; Early Career Lounge Located in Hall C for specialized programming, complimentary refreshments, and a comfortable space to relax for Student, Resident, Fellow, and Early Career Oncologists. #ASCO25 <a href="/ASCO/">ASCO</a> <a href="/SylvesterCancer/">Sylvester Comprehensive Cancer Center</a>
Emanuela Palmerini (@manupalmerini) 's Twitter Profile Photo

Do we have a new standard in 1st line for advanced UPS! 16 patients EPI IFO plus 360 mg nivolimab ORR 68.8% PFS Hi Will :) months 67% congrats #geis Nadia Hindi #undifferentiatedpleomorphicsarcoma

Do we have a new standard in 1st line for advanced UPS!
16 patients
EPI IFO plus 360 mg nivolimab
ORR 68.8%
PFS <a href="/18/">Hi Will :)</a> months 67%
congrats #geis <a href="/nadiahindi83/">Nadia Hindi</a> #undifferentiatedpleomorphicsarcoma
Emanuela Palmerini (@manupalmerini) 's Twitter Profile Photo

#Extraskeletalmyxoidchondrosarcoma (EMC)! With shnitinib + nivolumab: -6mPFS 77% -mPFS 1.2 months - 12 mOS rate 90% - 2/16 9% PR Well done Nadia Hindi Italian Sarcoma Group Javier Martin Broto ASCO #ASCO2025 #ultrarare #softtissuesarcoma

#Extraskeletalmyxoidchondrosarcoma (EMC)! With shnitinib + nivolumab:
-6mPFS 77%
-mPFS 1.2 months
- 12 mOS rate 90%
- 2/16 9% PR
Well done <a href="/nadiahindi83/">Nadia Hindi</a> <a href="/ItaSarcomaGroup/">Italian Sarcoma Group</a> <a href="/BrotoJavier/">Javier Martin Broto</a> <a href="/ASCO/">ASCO</a> #ASCO2025 #ultrarare #softtissuesarcoma
César Serrano García (@drcesarcoma) 's Twitter Profile Photo

🚨 New therapy approved in #sarcoma! EU Medicines Agency has granted the use of 🎯CSFR1 #vimseltinib in patients with #TGCT with funtion deterioration and in whom surgical options have been exhausted or would induce unacceptable morbidity or disability ▶️ema.europa.eu/en/medicines/h…

🚨 New therapy approved in #sarcoma!

<a href="/EMA_News/">EU Medicines Agency</a> has granted the use of 🎯CSFR1 #vimseltinib in patients with #TGCT with funtion deterioration and in whom surgical options have been exhausted or would induce unacceptable morbidity or disability

▶️ema.europa.eu/en/medicines/h…
CTOS (@ctosociety) 's Twitter Profile Photo

🌟New opportunity for Trainees and Junior Faculty of CTOS! We are launching a new initiative - the Young Investigator Group (YIG)! ⬇️Check below the details and apply or share with your young colleagues! It's an opportunity that can not be missed! 📩 applications [email protected]

🌟New opportunity for Trainees and Junior Faculty of CTOS! We are launching a new initiative - the Young Investigator Group (YIG)!
⬇️Check below the details and apply or share with your young colleagues! It's an opportunity that can not be missed!
📩 applications ctos@ctos.org